Kamath, Patrick S.

Endoscopy in liver disease by John N Plevris( )

9 editions published between 2017 and 2018 in English and held by 615 WorldCat member libraries worldwide

Intro -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- About the Companion Website -- Chapter 1 Equipment, Patient Safety, and Training -- Introduction -- Equipment -- Endoscopy Room Setup -- Endoscopic Stack -- Image Enhancing Modalities -- New Advances in Image Enhancement -- Endoscopes -- Accessories and Consumables -- Patient Safety and Training -- Cleaning and Disinfection of Endoscopes -- Patients -- Health Personnel and Training Issues -- Acknowledgment -- References -- Chapter 2 Sedation and Analgesia in Endoscopy of the Patient with Liver Disease -- Introduction -- Midazolam -- General -- Administration -- Propofol -- General -- Administration -- Opiate Analgesics -- Combination Therapy -- Combination of Midazolam with Fentanyl or Pethidine (Meperidine) -- Combination of Propofol with Midazolam -- Combination of Propofol with Fentanyl or Pethidine (Meperidine) -- Emergency Therapeutic Endoscopy -- Unsedated Endoscopy -- Conclusion -- References -- Chapter 3 Endoscopy in the Setting of Coagulation Abnormalities in the Patient with Liver Disease -- Introduction -- Coagulation Mechanism -- The "Normal" Patient -- The "Liver" Patient -- Measuring the Bleeding Risk in Liver Disease: Knowns and Unknowns -- Prophylactic Interventions: Advantages and Disadvantages -- Plasma -- Platelets -- Thrombopoietin Receptor Agonists -- Cryoprecipitate -- Clotting Factors -- Desmopressin -- Antifibrinolytic Agents -- Relative Risk of Endoscopic Procedures -- Colonoscopy with Polypectomy -- Variceal Band Ligation and Post-Banding Ulcer Bleeding -- Endoscopic Retrograde Cholangiopancreatogaphy and Sphincterotomy -- Rescue Approach -- Pharmacological Management of Portal Hypertension -- Platelets and Procoagulants -- Antifibrinolytics -- Conclusion -- References -- Chapter 4 Varices: Screening, Staging, and Primary Prophylaxis

Chronic liver failure : mechanisms and management by Pere Ginès( )

18 editions published between 2010 and 2011 in English and held by 410 WorldCat member libraries worldwide

Chronic liver failure is a frequent condition in clinical practice that encompasses all manifestations of patients with end-stage liver diseases. Chronic liver failure is a multiorgan syndrome that affects the liver, kidneys, brain, heart, lungs, adrenal glands, and vascular, coagulation, and immune systems. Chronic Liver Failure: Mechanisms and Management covers for the first time all aspects of chronic liver failure in a single book, from pathogenesis to current management. Each chapter is written by a worldwide known expert in their area and all provide the latest state-of-the-art knowledge. This volume is specifically designed to provide answers to clinical questions to all doctors dealing with patients with liver diseases, not only clinical gastroenterologists and hepatologists, but also to internists, nephrologists, intensive care physicians, and transplant surgeons

Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction by Frank Erhard Uschner( )

1 edition published in 2020 in English and held by 3 WorldCat member libraries worldwide

Abstract: Background & Aims<br>Phosphodiesterase-5 inhibitors (PDE-5-I) are used for treatment of erectile dysfunction (ED), which is common in patients with cirrhosis. They may improve portal hypertension (PH), but contradictory data on efficacy and side-effects have been reported. Non-selective beta blockers (NSBB) reduce portal pressure, but might aggravate ED. Thus, we evaluated the combination of PDE-5-I with NSBB and its impact on PH and ED in experimental cirrhosis.<br><br>Methods<br>ED was assessed in cirrhotic patients (n = 86) using standardized questionnaire. Experimental cirrhosis was induced by bile-duct-ligation or carbon-tetrachloride intoxication in rats. Corpus cavernosum pressure - a surrogate of ED -, as well as systemic and portal haemodynamics, were measured in vivo and in situ after acute administration of udenafil alone or in combination with propranolol. mRNA and protein levels of PDE-5 signalling were analysed using PCR and western Blot.<br><br>Results<br>ED in humans was related to severity of liver disease and to NSBB treatment. PDE-5 was mainly expressed in hepatic stellate cells and upregulated in human and experimental cirrhosis. Propranolol reduced corpus cavernosum pressure in cirrhotic rats and it was restored by udenafil. Even though udenafil treatment improved PH, it led to a reduction of mean arterial pressure. The combination of udenafil and propranolol reduced portal pressure and hepatic resistance without systemic side-effects.<br><br>Conclusions<br>ED is common with advanced cirrhosis and concomitant NSBB treatment. The combination of PDE-5-I and NSBB improves ED and PH in experimental cirrhosis

Live donor liver transplantation for alcoholic hepatitis by Ashwani K Singal( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Man xing gan shuai jie : ji zhi yu zhi liao = Chronic liver failure : mechanisms and management by Pere Ginès( Book )

1 edition published in 2012 in Chinese and held by 2 WorldCat member libraries worldwide

The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis by Jasmohan S Bajaj( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma by Michael L Wells( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

From Vitamin K Antagonists to Liver International Normalized Ratio: A Historical Journey and Critical Perspective( )

1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide

Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience by Jacqueline G O'Leary( )

1 edition published in 2020 in English and held by 2 WorldCat member libraries worldwide

Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience by Jacqueline G O'Leary( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide